p53 Staining Correlates With Tumor Type and Location in Sebaceous Neoplasms

被引:36
|
作者
Shalin, Sara C. [3 ]
Sakharpe, Aniket [4 ]
Lyle, Stephen [5 ]
Lev, Dina [4 ]
Calonje, Eduardo [6 ]
Lazar, Alexander J. [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Dermatol, Sect Dermatopathol, Houston, TX 77030 USA
[3] Baylor Coll Med, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA
[5] Univ Massachusetts, Med Ctr, Dept Canc Biol, Worcester, MA USA
[6] St Thomas Hosp, St Johns Inst Dermatol, London, England
基金
美国国家卫生研究院;
关键词
sebaceous adenoma; sebaceoma; sebaceous carcinoma; p53; Muir-Torre syndrome; DNA mismatch repair; microsatellite instability; MUIR-TORRE-SYNDROME; DNA MISMATCH REPAIR; CELL CARCINOMA; MSH2; MUTATIONS; EXPRESSION; BASAL; DIFFERENTIATION; PHENOTYPE; PROTEINS; ADJACENT;
D O I
10.1097/DAD.0b013e3181ed39f9
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Sebaceous neoplasms are commonly considered in their relationship to the Muir-Torre syndrome and the now well-documented loss of DNA mismatch repair proteins leading to microsatellite instability. However, sebaceous neoplasms showing microsatellite instability comprise only a subset of this group of tumors, and thus, alternative tumorigenic mechanisms must exist. This article explores the relationship of p53, a tumor suppressor implicated in other cutaneous malignancies, and sebaceous neoplasia. We examined 94 sebaceous tumors from 92 patients. Tumors with strong nuclear p53 staining were significantly associated with the diagnosis of sebaceous carcinoma compared with benign sebaceous lesions, most notably for periocular carcinomas. Importantly, nuclear mismatch repair protein expression was intact in all lesions showing p53 alterations, suggesting that p53 dysfunction may represent a divergent pathway in the molecular pathogenesis of these tumors.
引用
收藏
页码:129 / 138
页数:10
相关论文
共 50 条
  • [1] IMMUNOHISTOCHEMICAL STAINING FOR P53 IN SEBACEOUS GLAND CARCINOMAS OF THE OCULAR ADNEXA
    CARTER, SR
    CHAR, DH
    GHAZVINI, S
    CRAWFORD, JB
    SEIFF, SR
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S496 - S496
  • [2] P53 STAINING CORRELATES WITH CELL CYCLING IN UVEAL MELANOMA
    KISHORE, K
    GHAZVINI, S
    CHAR, DH
    SELLE, J
    KROLL, S
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1995, 36 (04) : S494 - S494
  • [3] Sebaceous carcinoma: Tumor progression through mutational inactivation of p53
    Dave, B
    Kaltreider, S
    Retief, JD
    Bao, Y
    Stoler, M
    Newman, S
    Levine, P
    GonzalezFernandez, F
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 1997, 38 (04) : 608 - 608
  • [4] Sebaceous carcinoma - Tumor progression through mutational inactivation of p53
    Gonzalez-Fernandez, F
    Kaltreider, SA
    Patnaik, BD
    Retief, JD
    Bao, YD
    Newman, S
    Stoler, MH
    Levine, PA
    OPHTHALMOLOGY, 1998, 105 (03) : 497 - 506
  • [5] MUTATIONS OF THE P53 TUMOR SUPPRESSOR GENE IN HEMATOLOGIC NEOPLASMS
    MORI, N
    WADA, M
    YOKOTA, J
    TERADA, M
    OKADA, M
    TERAMURA, M
    MASUDA, M
    HOSHINO, S
    MOTOJI, T
    OSHIMI, K
    MIZOGUCHI, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1992, 81 (02) : 235 - 240
  • [6] Aberrant expression of HDMX proteins in tumor cells correlates with wild-type p53
    Ramos, YFM
    Stad, R
    Attema, J
    Peltenburg, LTC
    van der Eb, AJ
    Jochemsen, AG
    CANCER RESEARCH, 2001, 61 (05) : 1839 - 1842
  • [7] p53 staining in trophoblastic diseases
    VanNoorden, S
    Barker, FG
    APPLIED IMMUNOHISTOCHEMISTRY, 1996, 4 (01): : 72 - 72
  • [8] TUMOR SUPPRESSOR P53 - ANALYSIS OF WILD-TYPE AND MUTANT P53 COMPLEXES
    MILNER, J
    MEDCALF, EA
    COOK, AC
    MOLECULAR AND CELLULAR BIOLOGY, 1991, 11 (01) : 12 - 19
  • [9] p53 as a target in myeloproliferative neoplasms
    Lu, Min
    Hoffman, Ronald
    ONCOTARGET, 2012, 3 (10) : 1052 - 1053
  • [10] P53 PROTEIN, PCNA STAINING, AND DNA CONTENT IN FOLLICULAR NEOPLASMS OF THE THYROID-GLAND
    CZYZ, W
    JOENSUU, H
    PYLKKANEN, L
    KLEMI, PJ
    JOURNAL OF PATHOLOGY, 1994, 174 (04): : 267 - 274